Companies / Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc.

Nasdaq: EIKNCIK 1861123MILLBRAE, CA

Ownership

54.1M shares outstanding · as of May 1, 2026
5.0%Insiders
Ownership
Insiders4.97%2,690,621
10%+ / strategic17.35%9,393,779
Institutions16.57%8,968,923
Public float61.11%33,085,305

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 31

View all →
Insider% of sharesShares
10.68%5,780,143
4.24%2,294,653
Wolfe JoshDirector · 10% owner
4.24%2,294,653
2.44%1,318,983
Perlmutter Roger MSee remarks · Director
0.53%284,857
0.21%111,111
Baynes Roy D.Chief Medical Officer
Bowie Alfred Lloyd Jr.Chief Financial Officer
Chen LeonDirector

Institutional holders 12

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
New$55.87M+4.3M
4,281,425
7.91% of shares
high
Q2 2026
as of
Merck & Co., Inc.
13F manager
New$21.75M+1.7M
1,666,666
3.08% of shares
medium
Q1 2026
as of
AllianceBernstein L.P.
13F manager
New$10.81M+1.0M
1,022,188
1.89% of shares
medium
Q1 2026
as of
Baker Bros. Advisors LP
13F manager
New$5.88M+556K
555,555
1.03% of shares
medium
Q2 2026
as of
State Street Corporation
13F manager
New$4.62M+354K
354,093
0.65% of shares
low
Q1 2026
as of
CPPIB Crestone Peak Resources Canada Inc.
13F manager
New$4.01M+379K
379,024
0.70% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
New$2.90M+274K
273,931
0.51% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
New$1.86M+176K
175,627
0.32% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Abu Dhabi Investment AuthorityPassive13G
Foresite Capital Fund IV, L.P.Passive13G
Perlmutter Roger MPassive13G

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
EIKN282564103